The Medical and Scientific Advisory team at Anavex Life Sciences provides expert guidance on the development and clinical strategy of therapeutics targeting neurodevelopmental and neurodegenerative diseases. Through collaboration and collaboration with cross-functional teams, they ensure that scientific rigor is applied to research initiatives, facilitate clinical trial design, and offer insights that enhance the understanding of drug mechanisms and patient outcomes. Their expertise is crucial for advancing Anavex's pipeline and achieving regulatory milestones.
Andrew J. Cole
Scientific Advisor
Corinne Lasmézas
Scientific Advisor
Dag Aarsland
Scientific Advisor
Daniel Weintraub
Scientific Advisor
Jeffrey Cummings
Scientific Advisor
John Harrison
Scientific Advisor
Norman Relkin
Scientific Advisor
Ottavio Arancio
Scientific Advisor
Paul Aisen
Scientific Advisor
Tangui Nicolas Mauri...
Scientific Advisor